Murray G Brown

Treatment of Guillain‐Barré syndrome: A cost‐effectiveness analysis

D. Anderson, G. Rock, S. Nagpal, 1999, Journal of clinical apheresis.

Societal Costs of Vascular Cognitive Impairment in Older Adults

J. Fisk, K. Rockwood, H. Merry, 2002, Stroke.

Hospital-based Psychiatric Service Utilization and Morbidity in Multiple Sclerosis

J. Fisk, M. Brown, C. Skedgel, 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Cost-effectiveness of disease-modifying therapies in the management of multiple sclerosis for the Medicare population.

Christopher McCabe, Jason Madan, Paul Tappenden, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost of disease-modifying therapies for multiple sclerosis

Murray G Brown, 2015, Neurology.

The Development of a Tool to Assess Quality of Cost Estimates

P. Jacobs, G. Finlayson, Ben Faienza, 2002 .

Hand dexterity and direct disease related cost in multiple sclerosis

J. Fisk, T. J. Murray, P. Jacobs, 2014, Journal of the Neurological Sciences.